• Serdar Gul, Ferit Kuscu, Hande Aydemir, Dogan Baris Ozturk, Ozcan Deveci, Fazilet Duygu, Birgul Kacmaz, Ferda Yaman, and Emel Aslan.
• Department of Infectious Diseases and Clinical Microbiology, Kirikkale University.
• Jpn. J. Infect. Dis. 2016 Jan 1; 69 (2): 109-12.

AbstractThe aim of this study was to investigate the incidence of acute kidney injury (AKI) and risk factors due to colistin use in patients infected with multidrug-resistant pathogens. This multicenter, retrospective, observational study was conducted in Turkey, at 5 different research and university hospitals. Cox regression analyses were performed, to determine independent predictors of AKI. From April 2012 to July 2014, a total of 216 patients aged between 18-94 years, treated with colistimethate sodium (CMS) were included in the study. The mean age of the patients was 60.3 ± 20.1 years. The overall incidence of AKI was 34.3% (74/216) at any time during treatment. Concomitant use of loop diuretics, baseline creatinine level, and CMS dosage were independently associated with AKI. According to our results, patients with higher baseline creatinine levels, or patients who had to use concomitant loop diuretics may need to be monitored more closely, and dose adjustment should be done promptly. More comprehensive studies are, however, still needed to evaluate the efficacy of low-dose colistin since higher doses tend to increase the risk of AKI.

27 keywords...

hide…